Characterization of Selenium Compounds for Anti-ferroptotic Activity in Neuronal Cells and After Cerebral Ischemia–Reperfusion Injury

[1]  A. Belaidi,et al.  Ferroptosis: mechanisms and links with diseases , 2021, Signal Transduction and Targeted Therapy.

[2]  A. Bush,et al.  CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease , 2020, British journal of pharmacology.

[3]  V. Swarup,et al.  Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke , 2019, Cell.

[4]  A. Bush,et al.  Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration , 2019, Free radical biology & medicine.

[5]  A. Bush,et al.  Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice , 2018, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.

[6]  A. Walch,et al.  Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis , 2017, Cell.

[7]  B. Stockwell,et al.  Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease , 2017, Cell.

[8]  A. Bush,et al.  Tau-mediated iron export prevents ferroptotic damage after ischemic stroke , 2017, Molecular Psychiatry.

[9]  J. Serratosa,et al.  Sodium selenate treatment improves symptoms and seizure susceptibility in a malin‐deficient mouse model of Lafora disease , 2017, Epilepsia.

[10]  G. Bornkamm,et al.  T cell lipid peroxidation induces ferroptosis and prevents immunity to infection , 2015, The Journal of experimental medicine.

[11]  X. Jia,et al.  Safety evaluation of Se-methylselenocysteine as nutritional selenium supplement: acute toxicity, genotoxicity and subchronic toxicity. , 2014, Regulatory toxicology and pharmacology : RTP.

[12]  A. Walch,et al.  Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice , 2014, Nature Cell Biology.

[13]  J. Uyehara-Lock,et al.  Selenium and selenoprotein function in brain disorders , 2014, IUBMB life.

[14]  Y. Rustum,et al.  Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models , 2014, British Journal of Cancer.

[15]  V. Gladyshev,et al.  Selenium and selenocysteine: roles in cancer, health, and development. , 2014, Trends in biochemical sciences.

[16]  M. Parnham,et al.  The early research and development of ebselen. , 2013, Biochemical pharmacology.

[17]  Holly L. Nicastro,et al.  Selenium and Prostate Cancer Prevention: Insights from the Selenium and Vitamin E Cancer Prevention Trial (SELECT) , 2013, Nutrients.

[18]  P. Kalivas,et al.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. , 2013, Antioxidants & redox signaling.

[19]  W. Wąsowicz,et al.  SeP, ApoER2 and megalin as necessary factors to maintain Se homeostasis in mammals. , 2012, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[20]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[21]  M. Rayman.  Selenium and human health , 2012, The Lancet.

[22]  S. Bandinelli,et al.  Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed , 2010, Movement disorders : official journal of the Movement Disorder Society.

[23]  V. Gladyshev,et al.  The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. , 2009, Molecular interventions.

[24]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[25]  K. Hall,et al.  Selenium level and cognitive function in rural elderly Chinese. , 2007, American journal of epidemiology.

[26]  C. Berr,et al.  Plasma Selenium Over Time and Cognitive Decline in the Elderly , 2007, Epidemiology.

[27]  R. Guigó,et al.  Characterization of Mammalian Selenoproteomes , 2003, Science.

[28]  L. Sher,et al.  Selenium and human health , 2000, The Lancet.

[29]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[30]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.

[31]  A. Wendel,et al.  A novel biologically active seleno-organic compound--II. Activity of PZ 51 in relation to glutathione peroxidase. , 1984, Biochemical pharmacology.

[32]  E. Cadenas,et al.  A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). , 1984, Biochemical pharmacology.

[33]  H. Ganther,et al.  SELENIUM AND GLUTATHIONE PEROXIDASE IN DEVELOPING RAT BRAIN 1 , 1976, Journal of neurochemistry.